Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04743141
Other study ID # BHV3000-312
Secondary ID C49510032020-003
Status Recruiting
Phase Phase 3
First received
Last updated
Start date April 28, 2021
Est. completion date May 5, 2027

Study information

Verified date May 2024
Source Pfizer
Contact Pfizer Pfizer CT.gov Call Center
Phone 1-800-718-1021
Email ClinicalTrials.gov_Inquiries@pfizer.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to test the long-term safety of rimegepant in the acute treatment of moderate or severe migraine in children and adolescents (≥ 6 to < 18 years of age).


Recruitment information / eligibility

Status Recruiting
Enrollment 200
Est. completion date May 5, 2027
Est. primary completion date December 31, 2024
Accepts healthy volunteers No
Gender All
Age group 6 Years to 17 Years
Eligibility Inclusion Criteria: 1. History of migraine (with or without aura) for = 6 months before Screening 2. History of 1 to 8 moderate or severe attacks per month during the 2 months prior to enrollment. 3. 1 or more migraine days requiring treatment during the Observation Phase. 4. Prophylactic migraine medication is permitted if the dose has been stable for at least 12 weeks prior to the Baseline Visit 5. Ability to distinguish between migraine and other types of headaches. 6. Weight = 40 kg at the Screening Visit. 7. Adequate venous access for blood sampling. 8. Male and female participants = 6 to < 18 years of age (participants must not reach their 18th birthday before enrollment into the study) Exclusion Criteria: 1. History of cluster headache or hemiplegic migraine headache. 2. Confounding and clinically significant pain syndrome 3. Current uncontrolled and/or untreated psychiatric condition for a minimum of 6 months prior to the Screening Visit (lifetime history of psychosis and/or mania are excluded). 4. History of suicidal behavior or major psychiatric disorder. 5. Current diagnosis or history of substance abuse; positive drug test at Screening.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Rimegepant / BHV3000
BHV3000 (rimegepant) 75 mg or 50 mg ODT

Locations

Country Name City State
Poland Wojewodzki Specjalistyczny Szpital Dzieciecy im. Sw. Ludwika w Krakowie Oddzial Kliniczny Dzieci Karkow
Poland NZOZ Wielospecjalistyczna Poradnia Lekarska SYNAPSIS, Lech Szczechowski Katowice
Poland NZOZ Wielospecjalistyczna Poradnia Lekarska SYNAPSIS, Lech Szczechowski Katowice
Poland Centrum Medyczne Plejady Krakow
Poland Wojewodzki Specjalistyczny Szpital Dzieciecy im. Sw. Ludwika w Krakowie Oddzial Kliniczny Dzieci Krakow
Poland Centrum Medyczne Plejady Kraków
Poland Clinical Research Center Sp. z o.o. Poznan
Poland Clinical Research Center Spólka z ograniczona odpowiedzialnoscia MEDIC-R Sp.k Poznan
Poland Euromedis Sp. z o.o. Osrodek B Szczecin,
Poland Centrum Medyczne Oporow Wroclaw
Poland Pracownia Badan Klinicznych SALUS Wroclaw
Spain Centre Atencio Primaria (CAP) Balenya Balenya Barcelona
Spain CAP Balenyà Barcelona
Spain Hospital Universitari Vall d'Hebron Barcelona
Spain Hospital Universitari Vall dHebron Barcelona
Spain Hospital Universitario Vall d'Hebron Barcelona
Spain Instituto de Investigaciones del Sueno Madrid
Spain Hospital Universitario Marques de Valdecilla Santander
Spain Hospital Universitario Marques de Valdecilla Santander Cantabria
Spain Hospital Universitario Virgen del Rocio Sevilla
Spain Hospital Universitario Virgen del Rocio (HUVR) Sevilla
Spain Hospital Clinico Universitario de Valladolid Valladolid
United States Dent Neurosciences Research Center Amherst New York
United States Advanced Research Center, Inc. Anaheim California
United States Michigan Head Pain and Neurological Institute Ann Arbor Michigan
United States Children's Healthcare of Atlanta - Center for Advanced Pediatrics Atlanta Georgia
United States Rare Disease Research LLC Atlanta Georgia
United States Children's Hospital Colorado Aurora Colorado
United States Children's Hospital Colorado Investigational Drug Services Aurora Colorado
United States Children's Hospital Colorado- Investigational Drug Services Aurora Colorado
United States Child Neurology Consultants of Austin - Central Austin Austin Texas
United States Child Neurology Consultants of Austin - South Austin Austin Texas
United States Dell Children's Medical Center Austin Texas
United States Velocity Clinical Research- Banning Banning California
United States Houston Clinical Trials, LLC Bellaire Texas
United States Northwest Clinical Research Center Bellevue Washington
United States Boston Clinical Trials Boston Massachusetts
United States Pivotal Clinical Research & Associates, LLC Brunswick Georgia
United States Physicians Research Group Chandler Arizona
United States Chicago Headache Center & Research Institute Chicago Illinois
United States Chicago Headache Center & Research Institute Chicago Illinois
United States The Neuron Clinic Chula Vista California
United States Cincinnati Children's Hospital Cincinnati Ohio
United States Drug Delivery-Cincinnati Children's IDS Denise Lagory Cincinnati Ohio
United States Velocity Clinical Research - Cincinnati Cincinnati Ohio
United States WellNow Urgent Care and Research Cincinnati Ohio
United States Novaceut Clinical Research Clarksville Tennessee
United States University Hospitals Cleveland Medical Center Cleveland Ohio
United States Colorado Springs Neurological Associates Colorado Springs Colorado
United States Wellnow Urgent Care and Research Columbus Ohio
United States Wellnow Urgent Care and Research Columbus Ohio
United States CT Clinical Research Cromwell Connecticut
United States ProScience Research Group Culver City California
United States Cedar Health Research Dallas Texas
United States Wellnow Urgent Care and Research Dayton Ohio
United States CenExel iResearch, LLC Decatur Georgia
United States Velocity Clinical Research-Providence East Greenwich Rhode Island
United States ANRC Research El Paso Texas
United States Eastside Therapeutic Resource, Inc. dba Core Clinical Research Everett Washington
United States Neuro-Pain Medical Center Fresno California
United States North Texas Institute of Neurology and Headache Frisco Texas
United States North Texas Institute of Neurology and Headache Frisco Texas
United States Sarkis Clinical Trials Gainesville Florida
United States Boeson Research - Grand Junction, CO Grand Junction Colorado
United States Boeson Research GJT Grand Junction Colorado
United States Boeson Research GJT Grand Junction Colorado
United States Dinosaur Pediatrics Grand Junction Colorado
United States Dinosaur Pediatrics Grand Junction Colorado
United States Corewell Health, for and on behalf of Spectrum Health Hospital and Corewell Health Medical Group Grand Rapids Michigan
United States Corewell Health, Helen DeVos Children's Hospital Grand Rapids Michigan
United States Outpatient Pediatric Neurology Clinic Grand Rapids Michigan
United States Velocity Clinical Research, Grants Pass Grants Pass Oregon
United States Boeson Research Great Falls Montana
United States Northwest Physicians Great Falls Montana
United States Headache Wellness Center Greensboro North Carolina
United States Headache Wellness Center, PC Greensboro North Carolina
United States Tribe Clinical Research LLC Greenville South Carolina
United States Velocity Clinical Research- Greenville Greenville South Carolina
United States Premier Neurology Greer South Carolina
United States Connecticut Children's Medical Center Hartford Connecticut
United States Boeson Research (HLN) Helena Montana
United States Houston Clinical Research,LLC. Houston Texas
United States Pain and Headache Centers of Texas Houston Texas
United States SCLA Management Houston Texas
United States Trio Clinical Trials, LLC. Houston Texas
United States Children's Clinical Research Center at Riley Hospital for Children at IU Health Indianapolis Indiana
United States Riley Hospital for Children at IU Health Indianapolis Indiana
United States Wellnow Urgent Care and Research Kalamazoo Michigan
United States Boeson Research,LLC Kalispell Montana
United States Sunwise Clinical Research Lafayette California
United States Multi-Specialty Research Associates, Inc. Lake City Florida
United States University of Kentucky Hospital Lexington Kentucky
United States Alivation Research, LLC Lincoln Nebraska
United States Miller Children's & Women's Hospital Long Beach Long Beach California
United States Children's Hospital Los Angeles - Children's Hospital Los Angeles Dept of Pharmacy Los Angeles California
United States Children's Hospital Los Angeles, Division of Neurology Los Angeles California
United States National Research Institute Los Angeles California
United States University Hospital Madison Wisconsin
United States University of Wisconsin-Madison Madison Wisconsin
United States Le Bonheur Children's Hospital Memphis Tennessee
United States Le Bonheur Childrens Hospital - Childrens Foundation Research Institute Memphis Tennessee
United States Le Bonheur Childrens Hospital - Outpatient Building Memphis Tennessee
United States AppleMed Research Group, LLC Miami Florida
United States Brainstorm Research Miami Florida
United States Medical Research Center of Miami II, Inc Miami Florida
United States South Florida Research Phase I-IV, Inc Miami Springs Florida
United States Boeson Research Missoula Montana
United States Access Clinical Trials, Inc. Nashville Tennessee
United States HMH Jersey Shore University Medical Center Neptune New Jersey
United States Ochsner Clinic Foundation New Orleans Louisiana
United States Columbia University Medical Center Research Pharmacy New York New York
United States Columbia University Pediatric Neuromuscular Center New York New York
United States Irving Center for Clinical and Translational Research, Outpatient Clinical Research Unit New York New York
United States Mount Sinai Hospital - Pharmacy Department New York New York
United States Mount Sinai Hospital - Pharmacy Department New York New York
United States New York Neurology Associates New York New York
United States The Neurological Institute of New York New York New York
United States Physicians Research Group (Administrative Office Location) Noblesville Indiana
United States Children's Hospital of The King's Daughters Norfolk Virginia
United States Children's Specialty Group, PLLC , Division of Childhood & Adolescent Neurology Norfolk Virginia
United States Coastal Carolina Research Center North Charleston South Carolina
United States Velocity Clinical Research - North Hollywood North Hollywood California
United States IPS Research Company Oklahoma City Oklahoma
United States Coastal Clinical Research Specialists Orange Park Florida
United States Orlando Health Arnold Palmer Hospital for Children Orlando Florida
United States Orlando Health Arnold Palmer Hospital for Children-Pediatric Specialty Practice Orlando Florida
United States College Park Family Care Center Physician Service Group - Neruology Research Department Overland Park Kansas
United States Sharlin Health Neuroscience Research Center Ozark Missouri
United States Children's Hospital of Philadelphia Philadelphia Pennsylvania
United States AIM Trials, LLC Plano Texas
United States The Neurology Group Pomona California
United States North Suffolk Neurology Port Jefferson Station New York
United States Providence Brain & Spine Institute-research coordinator's office Portland Oregon
United States Providence Health & Services Investigational Drug Services Westside Portland Oregon
United States Providence Portland Medical Center Portland Oregon
United States Providence St. Vincent Medical Center Portland Oregon
United States National Clinical Research, Inc. Richmond Virginia
United States Beaumont Hospital, Royal Oak Campus Royal Oak Michigan
United States UC Davis Sacramento California
United States UC Davis Medical Center, Investigational Drug Service (IDS) Pharmacy Sacramento California
United States University of California, Davis Clinical and Translational Science Center Clinical Research Center Sacramento California
United States University of California, Davis Midtown Clinic Sacramento California
United States JBR Clinical Research Salt Lake City Utah
United States Wasatch Clinical Research , LLC(Administrative Location) Salt Lake City Utah
United States Rady Children's Hospital San Diego California
United States Perseverance Research Center, LLC Scottsdale Arizona
United States Perseverance Research Center, LLC Scottsdale Arizona
United States Seattle Children's Hospital Seattle Washington
United States Seattle Children's Hospital Investigational Drug Services Seattle Washington
United States Clinvest Research, LLC Springfield Missouri
United States Clinvest Research, LLC Springfield Missouri
United States Ki Health Partners, LLc, dba New England Institute for Clinical Research Stamford Connecticut
United States ForCare Clinical Research Tampa Florida
United States Physicians Research Group Tempe Arizona
United States Pacific Clinical Research Management Group LLC Upland California
United States MedVadis Research Waltham Massachusetts
United States MedVadis Research Corporation Waltham Massachusetts
United States Premiere Research Institute at Palm Beach Neurology West Palm Beach Florida
United States Atrium Health Wake Forest Baptist Winston-Salem North Carolina

Sponsors (1)

Lead Sponsor Collaborator
Pfizer

Countries where clinical trial is conducted

United States,  Poland,  Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary The occurrence of treatment-emergent adverse events, serious adverse events To evaluate the safety and tolerability of rimegepant in children and adolescents (= 6 to < 18 years of age). 58 weeks
See also
  Status Clinical Trial Phase
Completed NCT01430442 - Dose Ranging Study of Rimegepant (BMS-927711) for the Acute Treatment of Migraine Phase 2